Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a study of the Eastern Cooperative Oncology Group (E9487)

Leukemia and Lymphoma

Volumn 33, Issue 1-2, 1999, Pages 127-133

  Kay, Neil ^a   Leong, Traci ^b   Kyle, Robert A ^c   Greipp, Phillip ^c   Van Ness, Brian ^d   Bone, Nancy ^a   Oken, Martin M ^a  

^a Virginia Piper Cancer Institute   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Altered T cell repertoire; CD4 lymphocytes; CD8 lymphocytes; Flow cytometry; Lymphocyte subsets; Multiple myeloma; Phenotype

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ARTICLE; B LYMPHOCYTE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VARIANCE;

EID: 0032970781     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909093733     Document Type: Article

References (24)

1. Kyle R.A. (1993) Newer approaches to the management of multiple myeloma. Cancer, 72, 3489-3494.
2. Mills K. H. G., Cawley J. C. (1983) Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma. Brit J Hemat, 53, 271-275.
3. San Miguel, J. F., Caballero, M. D., Gonzalez, M. (1985) Subpopulations in patients with monoclonal gammopathies: Essential monoclonal gammopathy, multiple myeloma, and Waldenstroms macroglobulinemia. Amer J Hemat, 20, 267-273.
4. Serra, H. M., Mant, M. J., Ruether, B. A., Ledbetter, J. A., Pilarski, L. M. (1988) Selective loss of CF4+, CD45R+T cells in peripheral blood of multiple myeloma patients. J Clin Immunol, 8, 259-264.
5. Pilarski, L. M., Andrews, E. J., Serra, H. M. et al (1989) Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance. Amer J Hemat, 30, 53-60.
6. Hoover, R. G., Kornbluth, J. (1992) Immunoregulation of murine and human myeloma. Hemat Oncol (N. A.), 6 (supplement 2), 407-424.
7. Zaknoen, S. L., Kay, N.E. (1990) Immunoregulatory cell dysfunction in chronic B-cell leukemias. Blood Revs, 4, 165-174.
8. Wen, T., Mellstedt, A., Jondal, M. (1990) Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma. J Exp Med, 171, 659-664.
9. Janson, C. H., Gruenwald, J., Osterborg, A. (1991) Predominant T cell receptor V gene usage in patients with abnormal clones of B cells. Blood, 77, 1776-1780.
10. Kay, N. E., Oken, M. M., Kyle, R. A. (1993) Detection of clonal blood T cell populations in multiple myeloma patients. Blood, 82 (supplement 1), 258a.
11. Moss, P. A., Gillespie, G., Frodsham, P., Bell, J. I. (1994) Clonal populations of CD4 and CD8 T cells in patients with paraprotinemia and myeloma. Blood, 84 (supplement), 177a.
12. Clark, S. P., Yoshikai, Y., Siu, G. (1994) Identification of a diversity segment ofthe human T cell receptor β chain, and comparison to the analogous murine element. Nature, 311, 387.
13. Hood, L., Kronenberg, M., Hunkapiller (1985) T cell antigen receptors and the immunoglobulin supergene family. Cell, 40, 225.
14. Moss, P. A. H., Rosenburg, W. M. C., Bell, J. The human T cell receptor in health and disease. Ann Rev Immunol, 10, 71-96.
15. Jorgensen, J., Reay, P., Ehrich, E. W., Davis, M. M. (1992) Molecular components of T cell recognition. Ann Rev Immunol, 10, 835.
16. Matis, L. A. (1990) The molecular basis of T cell specificity. Ann Rev Immunol, 8, 65.
17. Durie, B. G., Salmon, S. E. (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842-854.
18. Lehmann E. L. Nonparametrics: Statistical Methods Based on Ranks. Berkley, CA, Holden-Day, 1975.
19. Mokyr, M. B., Rubin, M., Newell, K. A. (1993) Involvement of TCR-Vβ8.3+ cells in the cure of mice bearing a large MOPC-315 tumor by low dose melphalan. J Immunol, 151, 4838-4846.
20. Scott, P., Kaufmann, S. H. E. (1991) The role of T cell subsets and cytokines in the regulation of infection. Immunol Today, 12, 346-348.
21. Swain, S. L., Bradley, L. M., Croft, M. (1991) Helper T cell subsets: phenotype function and the role of lymphokines in regulating their development. Immunol Rev, 123, 115-144.
22. Kay, N. E., Bone, N., Leong T., Oken, M. M., Kyle, R. A., Greipp, P. R., Van Ness, B. (1998) T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93. Brit J Haemat. 100, 459-463.
23. Farace F., Orlanducci, F., Dietrich, P. Y., et al (1994) T cell repertoire in patients with chronic B cell lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. J Immunol, 153, 4281.
24. Mackensen, A.G., Carcelain, G., Viel, S., et al (1993) Direct evidence to support the immunosurveillance concept in a human regressive melanoma J Clin Investigation, 93, 1397.